BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38353722)

  • 61. Use and Effectiveness of Adjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer in Men.
    Venigalla S; Carmona R; Guttmann DM; Jain V; Freedman GM; Clark AS; Shabason JE
    JAMA Oncol; 2018 Oct; 4(10):e181114. PubMed ID: 29800030
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus).
    Hind D; Wyld L; Beverley CB; Reed MW
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004272. PubMed ID: 16437480
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial.
    International Breast Cancer Study Group (IBCSG)
    J Natl Cancer Inst; 2002 Jul; 94(14):1054-65. PubMed ID: 12122096
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Radiation and/or endocrine therapy? Recurrence and survival outcomes in women over 70 with early breast cancer after breast-conserving surgery.
    Dahn H; Wilke D; Walsh G; Pignol JP
    Breast Cancer Res Treat; 2020 Jul; 182(2):411-420. PubMed ID: 32441018
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study.
    Bluethmann SM; Murphy CC; Tiro JA; Mollica MA; Vernon SW; Bartholomew LK
    Oncol Nurs Forum; 2017 May; 44(3):E101-E110. PubMed ID: 28635973
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.
    Burstein HJ; Lacchetti C; Anderson H; Buchholz TA; Davidson NE; Gelmon KA; Giordano SH; Hudis CA; Solky AJ; Stearns V; Winer EP; Griggs JJ
    J Clin Oncol; 2019 Feb; 37(5):423-438. PubMed ID: 30452337
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials.
    Qian X; Li Z; Ruan G; Tu C; Ding W
    Breast Cancer Res Treat; 2020 Jan; 179(2):275-285. PubMed ID: 31606823
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hormone Receptor Expression on Endocrine Therapy in Patients with Breast Cancer: A Meta-Analysis.
    Zhong Y; Ding B; Qian L; Wu W; Wen Y
    Am Surg; 2022 Jan; 88(1):48-57. PubMed ID: 33382340
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer.
    Shiba E; Yamashita H; Kurebayashi J; Noguchi S; Iwase H; Ohashi Y; Sasai K; Fujimoto T
    Breast Cancer; 2016 May; 23(3):499-509. PubMed ID: 25655898
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endocrine therapy as adjuvant or neoadjuvant therapy for breast cancer: selecting the best agents, the timing and duration of treatment.
    Li JJ; Shao ZM
    Chin Clin Oncol; 2016 Jun; 5(3):40. PubMed ID: 27164856
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.
    Mayer EL; Dueck AC; Martin M; Rubovszky G; Burstein HJ; Bellet-Ezquerra M; Miller KD; Zdenkowski N; Winer EP; Pfeiler G; Goetz M; Ruiz-Borrego M; Anderson D; Nowecki Z; Loibl S; Moulder S; Ring A; Fitzal F; Traina T; Chan A; Rugo HS; Lemieux J; Henao F; Lyss A; Antolin Novoa S; Wolff AC; Vetter M; Egle D; Morris PG; Mamounas EP; Gil-Gil MJ; Prat A; Fohler H; Metzger Filho O; Schwarz M; DuFrane C; Fumagalli D; Theall KP; Lu DR; Bartlett CH; Koehler M; Fesl C; DeMichele A; Gnant M
    Lancet Oncol; 2021 Feb; 22(2):212-222. PubMed ID: 33460574
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis.
    Poggio F; Ceppi M; Lambertini M; Bruzzi P; Ugolini D; Bighin C; Levaggi A; Giraudi S; D'Alonzo A; Vaglica M; Blondeaux E; Sertoli MR; Pronzato P; Del Mastro L
    Breast; 2017 Jun; 33():104-108. PubMed ID: 28360014
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adjuvant endocrine treatment for estrogen receptor (ER)-positive/HER2-negative breast cancer.
    Kubo M
    Chin Clin Oncol; 2020 Jun; 9(3):33. PubMed ID: 32527118
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic Value of Modified IHC4 Score in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer.
    Jin L; Chen K; Tan C; Li J; Luo J; Yang Y; Li Y; Li S; Zhu L; Hu Y; Liu F; You Q; Peng M; Jiang Z; Liu Q
    Oncologist; 2020 Aug; 25(8):e1170-e1180. PubMed ID: 32476192
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Predicting benefit of endocrine therapy for early breast cancer.
    Regan MM
    Breast; 2015 Nov; 24 Suppl 2(0 2):S129-31. PubMed ID: 26255197
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Are Social Deprivation and Low Traditional Health Literacy Associated With Higher PROMIS CAT Completion in Orthopaedic Surgery?
    Litvak AL; Lin NA; Hynes KK; Strelzow JA; Conti Mica MA; Stepan JG
    Clin Orthop Relat Res; 2024 Mar; 482(3):442-454. PubMed ID: 37732819
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.
    Jinih M; Relihan N; Corrigan MA; O'Reilly S; Redmond HP
    Breast J; 2017 Nov; 23(6):694-705. PubMed ID: 28252242
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?
    Herskovic AC; Wu X; Christos PJ; Nagar H
    Clin Breast Cancer; 2018 Oct; 18(5):418-431. PubMed ID: 29530585
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Winter-Roach BA; Kitchener HC; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.